GlaxoSmithKline on Monday issued an email blast to registrants of its MyAlli.com site that Alli will be making its way back to store shelves later this month.
GlaxoSmithKline has received a license extension in Europe for its popular weight-loss pill Alli.
GlaxoSmithKline Consumer Healthcare last week announced it will update the Alli product label to alert...
The Food and Drug Administration on Wednesday notified healthcare professionals and patients that it has...
The Food and Drug Administration on Monday issued a warning to consumers about a counterfeit...
This agency pulls no punches. The merest blip of a post-marketing serious adverse event report,...